2026 advances in canine atopic dermatitis management include improved biologics, refined immunotherapy protocols, and better understanding of the skin barrier dysfunction underlying the condition.
2026 advances in canine atopy management are expanding the treatment toolkit with more targeted biologics and improved immunotherapy protocols. Dogs with previously refractory atopy are achieving better welfare outcomes through more precisely targeted immunomodulation. Digital monitoring tools that track itch severity enable more responsive treatment adjustment, reducing the periods of uncontrolled itch that cause significant welfare suffering.